The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

Бібліографічні деталі
Автори:	Edge, J, Matthews, DR, Dunger, D
Формат:	Journal article
Мова:	English
Опубліковано:	1990

Increased overnight growth hormone concentrations in diabetic compared with normal adolescents.
за авторством: Edge, J, та інші
Опубліковано: (1990)

Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.
за авторством: Edge, J, та інші
Опубліковано: (1993)

Failure of current insulin regimes to meet the overnight requirements of adolescents with insulin-dependent diabetes.
за авторством: Edge, J, та інші
Опубліковано: (1990)

Spontaneous growth hormone (GH) pulsatility is the major determinant of GH release after thyrotrophin-releasing hormone in adolescent diabetics.
за авторством: Edge, J, та інші
Опубліковано: (1989)

Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty.
за авторством: Dunger, D, та інші
Опубліковано: (1991)

Impact of increased growth hormone secretion on carbohydrate metabolism in adolescents with diabetes.
за авторством: Dunger, D, та інші
Опубліковано: (1991)

The growth hormone releasing hormone (GHRH) response to a mixed meal is blunted in young adults with insulin-dependent diabetes mellitus whereas the somatostatin response is normal.
за авторством: Foot, AB, та інші
Опубліковано: (1990)

An unbiased glucose clamp method using a variable insulin infusion: its application in diabetic adolescents.
за авторством: Matthews, DR, та інші
Опубліковано: (1990)

The frequency and amplitude of growth hormone secretory episodes as determined by deconvolution analysis are increased in adolescents with insulin dependent diabetes mellitus and are unaffected by short-term euglycaemia.
за авторством: Pal, B, та інші
Опубліковано: (1993)

The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.
за авторством: Cheetham, T, та інші
Опубліковано: (1994)

The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
за авторством: Massoud, A, та інші
Опубліковано: (1996)

The effects of recombinant insulin-like growth factor I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus.
за авторством: Cheetham, T, та інші
Опубліковано: (1993)

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
за авторством: A. V. Vitebskaya, та інші
Опубліковано: (2021-11-01)

Half-life of exogenous growth hormone following suppression of endogenous growth hormone secretion with somatostatin in type I (insulin-dependent) diabetes mellitus.
за авторством: Mullis, P, та інші
Опубліковано: (1992)

The relationship between overnight GH levels and insulin concentrations in adolescents with insulin-dependent diabetes mellitus (IDDM) and the impact of recombinant human insulin-like growth factor I (rhIGF-I).
за авторством: Cheetham, T, та інші
Опубліковано: (1997)

Growth Hormone-Releasing Hormone in Diabetes
за авторством: Leonid Evsey Fridlyand, та інші
Опубліковано: (2016-10-01)

Contrasting metabolic effects of continuous and pulsatile growth hormone administration in young adults with type 1 (insulin-dependent) diabetes mellitus.
за авторством: Pal, B, та інші
Опубліковано: (1992)

Does recombinant insulin-like growth factor I have a role in the treatment of insulin-dependent diabetes mellitus during adolescence?
за авторством: Dunger, D, та інші
Опубліковано: (1993)

The correlation of dawn phenomenon with glycemic variability parameters in type 2 diabetes mellitus
за авторством: Roman Gabriela, та інші
Опубліковано: (2016-03-01)

The effect of moderate weight loss on overnight growth hormone and cortisol secretion in healthy female volunteers.
за авторством: Anderson, I, та інші
Опубліковано: (1989)

THE OVERNIGHT CONSULTANT /
за авторством: Lewin, Marsha D. 242587
Опубліковано: (1995)

Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.
за авторством: Amin, R, та інші
Опубліковано: (2005)

The pituitary gland is capable of responding to two successive doses of growth hormone releasing hormone (GHRH)
за авторством: Suri, D, та інші
Опубліковано: (1991)

The interaction of growth hormone releasing hormone and somatostatin in the generation of a GH pulse in man.
за авторством: Hindmarsh, P, та інші
Опубліковано: (1991)

Growth-hormone-releasing factor in growth hormone deficiency: demonstration of a hypothalamic defect in growth hormone release.
за авторством: Grossman, A, та інші
Опубліковано: (1983)

Growth hormone releasing hormone.
за авторством: Grossman, A, та інші
Опубліковано: (1986)

Continuous subcutaneous growth hormone releasing factor analogue augments growth hormone secretion in normal male subjects with no desensitization of the somatotroph.
за авторством: Brain, C, та інші
Опубліковано: (1988)

Self-Monitoring of Blood Glucose to Assess Dawn Phenomenon in Chinese People with Type 2 Diabetes Mellitus
за авторством: Wen Wu, та інші
Опубліковано: (2017-01-01)

THE CHARACTERISTICS OF GROWTH-HORMONE (GH) PULSATILITY IN NEONATES
за авторством: Adcock, C, та інші
Опубліковано: (1994)

The effect of prolonged fasting on levels of growth hormone-binding protein and free growth hormone.
за авторством: Salgin, B, та інші
Опубліковано: (2012)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
за авторством: Korbonits, M, та інші
Опубліковано: (1998)

Treatment of growth-hormone deficiency with growth-hormone-releasing hormone.
за авторством: Ross, R, та інші
Опубліковано: (1987)

The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
за авторством: Achermann, J, та інші
Опубліковано: (1999)

The interaction of growth hormone releasing hormone with other hypothalamic hormones on the release of anterior pituitary hormones.
за авторством: Looij, B, та інші
Опубліковано: (1986)

A probabilistic computation framework to estimate the dawn phenomenon in type 2 diabetes using continuous glucose monitoring
за авторством: Souptik Barua, та інші
Опубліковано: (2024-02-01)

The effect of changing somatostatin tone on the pituitary growth hormone and thyroid-stimulating hormone responses to their respective releasing factor stimuli.
за авторством: Spoudeas, H, та інші
Опубліковано: (1992)

Patient and provider perceptions of care for diabetes: results of the cross-national DAWN Study.
за авторством: Peyrot, M, та інші
Опубліковано: (2006)

GROWTH HORMONE-RELEASING HORMONE-TREATMENT OF GROWTH-HORMONE DEFICIENT CHILDREN
за авторством: Ross, R, та інші
Опубліковано: (1986)

Phenomenon of the “dawn attacks operation” as a money politics practices in Indonesian election
за авторством: Yusa Djuyandi, та інші
Опубліковано: (2024-08-01)

The dawn phenomenon is related to overnight growth hormone release in adolescent diabetics.

Схожі ресурси

Схожі ресурси